Cannabis Brands

Accounting for Colorado Cannabis Brands

A growing number of Colorado cannabis companies operate as brands — owning the intellectual property, marketing and customer relationships while contracting cultivation, manufacturing or packaging to licensed partner facilities. That model raises accounting questions a straightforward operator never faces: royalty recognition, licensing revenue, and where 280E actually applies when the brand itself never touches the plant.

Cannabis accountants reviewing financial reports and margin analytics on screen in a Denver executive office

Financial challenges specific to this license type

  • Royalty and licensing revenue recognition

    Brands earning a royalty or licensing fee from a manufacturing partner need revenue recognition policies that match the underlying agreement — whether that's a percentage of net sales, a per-unit fee, or a minimum guarantee — and that hold up under audit.

  • Determining where 280E actually attaches in a licensing structure

    If a brand never takes title to cannabis and earns only licensing income, its 280E exposure looks very different from an operator that cultivates or sells product directly. That determination depends on the specific contractual structure and needs a documented position, not a guess.

  • Multi-entity reporting across brand, manufacturing and retail partners

    Brand companies often sit alongside separate licensed entities for manufacturing and distribution, sometimes under common ownership. Consolidated reporting and related-party transaction documentation both need careful handling to avoid IRS or MED scrutiny.

  • Marketing and intangible asset accounting

    Trademark development, packaging design and brand marketing spend represent real intangible value, but the treatment of these costs — capitalize versus expense — affects both financial statements presented to investors and the federal tax position.

How we work with cannabis brands

  • Design revenue recognition policies for royalty, licensing and wholesale brand arrangements
  • Document the brand entity's 280E exposure based on its actual contractual structure
  • Build consolidated and related-party reporting across brand, manufacturing and retail entities
  • Advise on capitalization versus expensing of trademark, packaging and marketing costs
  • Support due diligence financials for brand licensing and partnership negotiations
  • Coordinate tax filings across every entity in a multi-license brand structure

Royalty and licensing revenue recognition

A growing number of Colorado cannabis companies operate as brands — owning intellectual property, marketing, and customer relationships while contracting cultivation, manufacturing, or packaging to licensed partner facilities. A brand earning a royalty or licensing fee from a manufacturing partner needs a revenue recognition policy that matches the underlying agreement, whether that's a percentage of net sales, a per-unit fee, or a minimum guarantee, and that policy needs to hold up if it's ever tested by an auditor or acquirer.

Where 280E attaches in a licensing structure

If a brand never takes title to cannabis and earns only licensing or royalty income, its 280E exposure looks materially different from an operator that cultivates or sells product directly. That determination depends entirely on the specific contractual structure between the brand and its manufacturing or retail partners, and it needs a documented, fact-specific position rather than a default assumption in either direction.

We review the actual licensing and manufacturing agreements to determine and document where the brand entity's federal tax exposure genuinely sits, which also informs how the entity should be structured relative to its plant-touching partners.

Multi-entity and related-party reporting

Brand companies often sit alongside separate licensed entities for manufacturing and distribution, sometimes under common ownership. Consolidated financial reporting and careful related-party transaction documentation both matter here — inconsistent or undocumented intercompany pricing between the brand and its manufacturing partner is a common trigger for IRS or MED scrutiny.

  • Revenue recognition policies matched to each licensing or royalty agreement
  • Documented 280E position based on the brand's actual contractual role
  • Consolidated and related-party reporting across brand, manufacturing, and retail entities

Capitalizing brand-building costs correctly

Trademark development, packaging design, and brand marketing spend represent real, sometimes significant, intangible value, but whether those costs get capitalized or expensed affects both the financial statements presented to investors and the underlying federal tax position. We advise on that treatment deliberately, rather than defaulting to whatever a generic small-business bookkeeping template does with marketing spend.

Services most relevant to this operator profile

Questions

Cannabis Brands accounting questions

Consultation

Speak with a Cannabis CPA Colorado

Bring your license types, current books and open deadlines. We will tell you what needs to happen first and in what order.